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Penetrating traumatic brain injury(PTBI) is common in the USA and worldwide, outcome 
remains poor in survivors. In the absence of “neuroprotective” therapies, progressive secondary 
tissue loss after PTBI underlies disability among survivors. This study tests transplantation of 
human neural stem cells (hNSCs) as a treatment to mitigate lesion in penetrating ballistic-like 
brain injury (PBBI), a rat PTBI model. One-week post PBBI male Sprague Dawley rats (7-
10/group) were randomized to: (1) injured treated with vehicle (media, no cells), (2) uninjured 
(sham+hNSCs), two PBBI groups (PBBI+hNSC) either (3) into surrounding (peri) or (4) within 
lesion core(intra), one million cells were stereotactically microinjected into brains of 
immunosuppressed group 2-4. Motor function was assessed on grid walk prior to euthanasia at 
12 weeks post-transplantation. Lesion size, axonal injury was quantitated with Matlab based 
scripts of brain sections stained with histochemical stains. Lesion size and remote secondary 
axotomy were significantly reduced in transplant groups. Engraftment or neuronal differentiation 
did not differ between groups 3 and 4, despite being higher than in sham. On the grid walk test, 
sham animals had fewer foot faults than vehicle group as expected. Compared to vehicle, groups 
3 and 4 had significantly reduced foot faults but still significantly higher than control.  
A two-way ANOVA of the rat brain cortical tissue quantity between +3.72 mm and -0.28 mm 
bregma (rat motor cortex) there was significant interaction between bregma levels and treatment. 
There was reduction in lesion size in both transplant groups (p<0.05). Lesion seize reduction was 
due to significant increase in tissue sparing in the perilesional transplant group compared to 
vehicle (p<0.01). One-way ANOVA revealed no statistically significant differences in spared 
tissue between two transplant groups but greater sparing of the motor cortex in perilesional 
transplantation. The concomitant reduction in lesion area and increased cortical tissue sparing 
suggests that transplantation of hNSCs reduced the progression of PBBI induced cortical 
atrophy, spared motor cortex reduced secondary axotomy may be associated with improved 
motor performance in transplant groups. This data provides a rationale for use of hNSC 
transplants to mitigate PTBI induced secondary tissue loss. Perilesional rather than intralesional 
transplantation conferred greater neuroprotection.  
 
